(2021) 'Glutathione in the brain', International Journal of Molecular Sciences , 22(9), 5010
Vomiting affected 31% of high-dose participants, while diarrhea occurred in 23% of patients
Based on published trial data to date, serious side effects were relatively uncommon in controlled clinical trial settings
April 1, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
Spoering, D
Semaglutide and tirzepatide modestly slow gut transit, which can create a favorable environment for Akkermansia growth